New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
08:38 EDTINSMInsmed says to pursue breakthrough therapy designation for Arikayce in the U.S.
Says seeking the "most expeditious path forward" for Arikayce in the EU. Doctors involved in the trial says saw "encouraging" signs in trial, and the company said it is "encouraged" by the achievement of culture conversion in the Phase 2 trial. Comments from the company's conference call discussing results from its U.S. phase 2 clinical trial for treatment resistant nontuberculous mycobacteria lung infections.
News For INSM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
13:54 EDTINSMInsmed personnel strong, says Piper Jaffray
After attending Insmed's analyst event, Piper says that the company has assembled a strong development and commercial team . The firm adds that the company has forged unique relationships with specialists and patients. It keeps an Overweight rating on the shares.
March 23, 2015
09:06 EDTINSMInsmed appoints Eugene Sullivan as Chief Medical and Scientific Officer
Subscribe for More Information
March 20, 2015
09:25 EDTINSMInsmed to host analyst and investor day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use